We are live on
!
Find out more
Kymera Therapeutics
KYMR
KYMR
127 hedge funds and large institutions have $1.68B invested in Kymera Therapeutics in 2023 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 46 increasing their positions, 41 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
745% more call options, than puts
Call options by funds: $22M | Put options by funds: $2.6M
60% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 10
50% more funds holding in top 10
Funds holding in top 10: 4 → 6 (+2)
21% more capital invested
Capital invested by funds: $1.39B → $1.68B (+$290M)
12% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 41
5% more funds holding
Funds holding: 121 → 127 (+6)
0.74% more ownership
Funds ownership: 102.31% → 103.05% (+0.74%)
Holders
127
Holders Change
+6
Holders Change %
+4.96%
% of All Funds
2.02%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.1%
New
16
Increased
46
Reduced
41
Closed
10
Calls
$22M
Puts
$2.6M
Net Calls
+$19.4M
Net Calls Change
-$1.31M
Top Buyers
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
+$13.8M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$10.9M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$9.27M |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$6.62M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$5.68M |
